Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.90 USD
Change Today +0.12 / 1.02%
Volume 3.8K
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 3:19 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Key Developments

Misonix, Inc. Announces Resignation of Thomas F. O’Neill from the Board

On May 13, 2015, Thomas F. O’Neill notified the board of directors of Misonix, Inc. that he was resigning from the board of the company effective immediately.

Misonix, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015; Provides Earnings Guidance for 2015

Misonix, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported net sales of $5,314,797 against $4,284,645 a year ago. The increase was attributable to a 27% increase in BoneScalpel revenue to $2.2 million, a 30% increase in SonaStar revenue to $2.0 million and a 16% increase in SonicOne revenue to $847,000. Loss from operations was $812,537 against $643,429 a year ago. Income from continuing operations before income taxes was $213,050 against $182,170 a year ago. Net income from continuing operations was $204,644 against $173,794 a year ago. Net income was $454,340 against $428,770 a year ago. Diluted net income per share was $0.05 against $0.05 a year ago. Diluted net income per share from continuing operations was $0.02 against $0.02 a year ago. Domestic revenue for the third quarter of fiscal 2015 was $2.6 million compared to $2.3 million for the same period in fiscal 2014. For the nine months, the company reported net sales of $15,455,142 against $11,482,288 a year ago. The increase was attributable to a 42% increase in BoneScalpel revenue to $7.4 million, a 35% increase in SonaStar revenue to $5.3 million and a 32% increase in SonicOne revenue to $2.3 million. Loss from operations was $1,672,686 against $2,783,202 a year ago. Income from continuing operations before income taxes was $1,535,311 against loss from continuing operations before income taxes of $246,944 a year ago. Net income from continuing operations was $1,479,088 against loss from continuing operations of $260,820 a year ago. Net income was $1,738,734 against $4,106 a year ago. Diluted net income per share was $0.21 against $0.00 a year ago. Diluted net income per share from continuing operations was $0.18 against LPS of $0.04 a year ago. The company expects the momentum of the first three quarters to continue into the fourth quarter of fiscal 2015. The financial underpinnings of the company remain strong, with cash and equivalents approaching $9 million, no long-term debt, and operations funded from internally generated cash flow. The company expects to continue to drive solid operational and financial results and to close out fiscal 2015.

Misonix, Inc. to Report Q3, 2015 Results on May 07, 2015

Misonix, Inc. announced that they will report Q3, 2015 results at 4:30 PM, US Eastern Standard Time on May 07, 2015

Misonix, Inc., Q3 2015 Earnings Call, May 07, 2015

Misonix, Inc., Q3 2015 Earnings Call, May 07, 2015

Misonix Signs Exclusive Supply Agreement with MedAssets

Misonix announced the launch of an exclusive three-year national supply contract with MedAssets. With MedAssets serving four out of five US hospitals and approximately 123,000 non-acute healthcare providers, Misonix has entered into this exclusive agreement for its BoneScalpel and SonicOne surgical technologies. This is simply a great opportunity for many more healthcare facilities and their patients to ultimately benefit from its BoneScalpel and SonicOne surgical technologies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $11.90 USD +0.12

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.36 USD +0.01
Globus Medical Inc $25.60 USD -0.17
NuVasive Inc $48.35 USD +0.12
Smith & Nephew PLC 1,134 GBp -6.00
Synergetics USA Inc $4.52 USD +0.07
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings 33.3x
Price/Sales 4.3x
Price/Book 4.7x
Price/Cash Flow 29.0x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.